Tsao Lab

Rashid S, Tsao H

Recognition, Staging, and Management of Melanoma.
Med Clin North Am. 2021;105(4):643-661 - PMID: 34059243 - DOI: 10.1016/j.mcna.2021.04.005

Rashid S, Tsao H

Effect of the COVID-19 Pandemic on Delayed Skin Cancer Services.
Dermatol Clin. 2021;39(4):627-637 - PMID: 34556252 - PMCID: PMC8162820 - DOI: 10.1016/j.det.2021.05.015

Guhan SM, Shaughnessy M, Rajadurai A, Taylor M, Kumar R, Ji Z, Rashid S, Flaherty K, Tsao H

The Molecular Context of Vulnerability for CDK9 Suppression in Triple Wild-Type Melanoma.
J Invest Dermatol. 2021;141(8):2018-2027.e4 - PMID: 33745909 - PMCID: PMC8316294 - DOI: 10.1016/j.jid.2020.12.035

Coroiu A, Moran C, Davine JA, Brophy K, Bergeron C, Tsao H, Körner A, Swetter SM, Geller AC

Patient-identified early clinical warning signs of nodular melanoma: a qualitative study.
BMC Cancer. 2021;21(1):371 - PMID: 33827477 - PMCID: PMC8028760 - DOI: 10.1186/s12885-021-08072-4

Atkins MB, Curiel-Lewandrowski C, Fisher DE, Swetter SM, Tsao H, Aguirre-Ghiso JA, Soengas MS, Weeraratna AT, Flaherty KT, Herlyn M, Sosman JA, Tawbi HA, Pavlick AC, Cassidy PB, Chandra S, Chapman PB, Daud A, Eroglu Z, Ferris LK, Fox BA, Gershenwald JE, Gibney GT, Grossman D, Hanks BA, Hanniford D, Hernando E, Jeter JM, Johnson DB, Khleif SN, Kirkwood JM, Leachman SA, Mays D, Nelson KC, Sondak VK, Sullivan RJ, Merlino G, Melanoma Research Foundation

The State of Melanoma: Emergent Challenges and Opportunities.
Clin Cancer Res. 2021;27(10):2678-2697 - PMID: 33414132 - PMCID: PMC8127340 - DOI: 10.1158/1078-0432.CCR-20-4092

Njauw CN, Ji Z, Pham DM, Simoneau A, Kumar R, Flaherty KT, Zou L, Tsao H

Oncogenic KIT Induces Replication Stress and Confers Cell Cycle Checkpoint Vulnerability in Melanoma.
J Invest Dermatol. 2021;142(5):1413-1424.e6 - PMID: 34687746 - DOI: 10.1016/j.jid.2021.07.188
6